How to Build Investment Committee Memos That Hold Up

A polished demo is not an investment case. Neither is a founder who can explain a market slide with religious conviction. Yet many committees still receive memos that turn those inputs into a recommendation, then call the result diligence.

To build investment committee memos that hold up, treat the memo as a decision record, not a deal brochure. Its job is to make the central underwriting claim visible, testable, and hard to misinterpret six months after capital moves. If the recommendation cannot survive a skeptical reader who was not in the founder meeting, it is not ready for committee.

For AI, blockchain, and data infrastructure investments, that standard matters more than usual. The gap between an impressive prototype and a deployable business is wide. The gap between pilot revenue and repeatable demand is wider. A serious memo closes neither gap with adjectives.

Start With the Decision, Not the Company Story

Most weak memos begin with the company history, founder biographies, and a large market estimate. That structure is comfortable because it postpones the hard question: what exactly must be true for this investment to work?

Put the recommendation upfront. State whether the proposed action is to invest, pass, or defer pending specific evidence. Then name the underwriting thesis in a sentence that could be proven wrong.

For example: the company can become a meaningful enterprise data platform because its integration architecture reduces deployment time for a defined buyer, creating retention that competitors cannot easily replicate. That is a thesis. “Large market, exceptional team, strong AI tailwinds” is mood lighting.

The next section should identify the few assumptions carrying the decision. For an early-stage infrastructure company, those may include a painful and funded buyer problem, a product that works under production constraints, a viable path through security and procurement, credible unit economics, and an advantage that survives once incumbents copy surface features.

Do not create a list of twenty risks to signal thoroughness. Committee members do not need a catalog of every bad thing that can happen. They need to know which three to five things would break the case, what evidence exists for each, and what remains unproven.

Build Investment Committee Memos Around Evidence Quality

Not all evidence deserves equal weight. A founder saying customers love the product is not evidence of durable demand. A signed contract may not be either, depending on contract length, implementation status, expansion rights, and whether the customer actually uses the product after the executive sponsor leaves the room.

Separate facts into three categories: verified operating evidence, management claims, and analyst inference. This sounds elementary. It is also routinely skipped when investors are trying to keep pace with a hot category.

Verified evidence includes product telemetry, cohort retention, signed and reviewed customer agreements, reference calls, implementation timelines, security documentation, architecture review, and a clear view of cash movement. Management claims include pipeline, expected conversion, future margins, and verbal customer enthusiasm. Analyst inference is where you explain what the facts mean and where the facts do not yet support confidence.

Labeling these categories prevents a common failure: a forecast is repeated enough times that it starts to look like a result. It is still a forecast. The committee should be able to see the boundary without hunting through footnotes.

For AI companies, inspect the underlying workflow rather than accepting capability claims at face value. Ask what the model does, where human review is required, what happens when inputs are incomplete, what the inference and support costs are, and whether the product is improving a workflow customers already budget for. A system that performs beautifully in a controlled demo but fails on messy source data is not a minor product issue. It may be the entire investment risk.

For blockchain and data infrastructure, the same discipline applies in different clothing. What is decentralized because it creates a real economic or technical advantage, rather than because the fundraising deck needed a category label? What data is proprietary, reliably accessible, and legally usable? What part of the stack becomes harder to replace as customers scale? A diagram is not defensibility.

Make Customer Reality the Center of the Memo

The market section should not be a rehearsal of industry statistics. Large markets do not buy software. Specific buyers do, through constrained budgets, legacy systems, procurement gates, and internal politics.

Define the initial customer precisely: the economic buyer, the daily user, the technical owner, the current workaround, and the event that makes change urgent. If those roles are unclear, the company may have interest but not a route to revenue.

Then assess whether the company has found real pull. Paid deployments matter more than design partners. Renewals matter more than pilots. Expansion matters more than logo count. None of these metrics is universally sufficient, because enterprise sales cycles and deployment complexity vary. But the memo should explain what evidence is appropriate for this company at this stage, not import a generic SaaS benchmark and pretend the comparison settles anything.

Reference calls deserve more than a favorable quote. Capture what the customer deployed, how long it took, who owned implementation, where the product disappointed, what they would do if the vendor disappeared, and whether the purchase is likely to expand. Ask whether the customer would buy again at the current price. That answer is usually more useful than a Net Promoter Score produced under the watchful eye of a champion.

Test the Commercial Model Against the Product

A technical advantage is not automatically a commercial advantage. Many teams can build a useful system. Fewer can package it, price it, implement it, and support it without turning every customer into a custom engineering project.

Your memo should connect the product architecture to the go-to-market model. If revenue depends on a heavy services layer, say so. Services can be rational in the early years, particularly in complex data environments. The problem is not services. The problem is calling services revenue software scale while gross margins, onboarding capacity, and sales cycles tell a different story.

Examine concentration, contract structure, implementation cost, gross margin trajectory, churn risk, and the cash required to reach the next financing or breakeven milestone. Use ranges where precision would be false. A single revenue projection with three decimal places is not rigor. It is spreadsheet theater.

The same applies to competitive analysis. Name the credible alternatives: internal builds, incumbent platforms, adjacent vendors, and doing nothing. “No direct competitors” usually means the team has not looked hard enough, or the market has not validated the problem.

Write the Risks So They Can Change the Outcome

A risk section should alter the recommendation, valuation, ownership target, or diligence plan. If it does none of those things, it is decorative.

Each material risk needs a mechanism, an indicator, and a response. For instance, if adoption depends on integration with fragmented customer data, the mechanism is implementation failure or prolonged time-to-value. Indicators might include stalled deployments, reliance on founder-led integration, or customers failing to activate key workflows. The response could be a milestone-based tranche, a request for deeper technical diligence, or a decision to wait.

This approach is particularly useful when the right answer is not a clean pass. Some opportunities are promising but premature. “Defer until the company shows repeatable deployment across a defined customer segment” is a stronger decision than forcing a yes because the category is moving quickly. Missing a deal is cheaper than underwriting fiction.

End With a Recommendation That Is Operational

The final recommendation should tell the committee what to do and under what conditions. Include proposed check size, valuation context, ownership implications, the evidence that supports conviction, the unresolved issues, and any conditions precedent to closing.

If you recommend investing, state what would make the decision wrong. If you recommend passing, state what evidence would change your mind. This is not hedging. It is intellectual honesty, and it creates a usable record for future learning.

The best investment committee memos do not manufacture certainty. They force a better kind of discomfort: the discomfort of seeing where the case is thin before money makes it expensive to admit. That is the point. Capital should move because the thesis survived contact with evidence, not because the room was briefly hypnotized by a demo.

Where is your leadership effective, and where is it costing the company?

Most of the problems this blog covers trace back to how the founder runs the company. The Trellis Leadership Diagnostic maps that in 24 behavior-anchored items across six dimensions: about 12 minutes, instant results, free to take self-serve.

Take the Leadership Diagnostic →

Exploring a fractional or advisory engagement instead? Book a discovery call →